Key Market Indicators
Icelander Antihypertensive Medicine Sales are set to reach $750,000 by 2026, growing at a rate of 2.3% year on year. Since 1994, demand for these products in Iceland has been steadily increasing at 10.5% year on year. In 2021, Iceland ranked 25th in terms of total sales, with Costa Rica one position ahead at $660,000. Italy, Spain and Australia occupied the 2nd, 3rd and 4th positions in the ranking, respectively.
